Thus, we propose that atypical IκBs serve to enhance flexibility for the use of NF‐κB‐dependent gene regulation and harmonize this functionality with other pathways such as control of chromatin accessibility or cell metabolism with—if disturbed—important consequences for autoimmune disorders and intestinal inflammation. Here, NFKB1 is linked to autoimmune disease.